Cerity Partners LLC Catalent, Inc. Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 6,149 shares of CTLT stock, worth $373,551. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,149

Previous 5,047 21.83%

Holding current value

$373,551

Previous $283,000 31.45%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.16 - $60.96 $61,888 - $67,177	1,102 Added 21.83%	6,149 $372,000
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $76,833 - $81,766	-1,434 Reduced 22.13%	5,047 $283,000
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $275,831 - $387,693	6,481 New	6,481 $365,000
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $351,251 - $574,029	7,730 Added 29.31%	34,107 $2.24 Million
Q4 2022 Feb 15, 2023	BUY	$41.39 - $81.0 $256,411 - $501,795	6,195 Added 30.7%	26,377 $1.19 Million
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $102,172 - $159,697	1,412 Added 7.52%	20,182 $1.46 Million
Q2 2022 Aug 10, 2022	BUY	$87.2 - $114.05 $16,393 - $21,441	188 Added 1.01%	18,770 $2.01 Million
Q1 2022 Apr 25, 2022	BUY	$94.19 - $124.49 $113,404 - $149,885	1,204 Added 6.93%	18,582 $2.06 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $107,971 - $125,580	903 Added 5.48%	17,378 $2.23 Million
Q3 2021 Oct 25, 2021	SELL	$109.17 - $142.35 $422,597 - $551,036	-3,871 Reduced 19.03%	16,475 $2.19 Million
Q2 2021 Aug 11, 2021	BUY	$100.34 - $115.69 $45,052 - $51,944	449 Added 2.26%	20,346 $2.2 Million
Q1 2021 Aug 11, 2021	SELL	$101.51 - $125.27 $609 - $751	-6 Reduced 0.03%	19,897 $2.1 Million
Q1 2021 May 12, 2021	SELL	$101.51 - $125.27 $171,754 - $211,956	-1,692 Reduced 7.84%	19,903 $2.1 Million
Q4 2020 Feb 11, 2021	SELL	$85.88 - $105.36 $13,826 - $16,962	-161 Reduced 0.74%	21,595 $2.25 Million
Q3 2020 Nov 12, 2020	SELL	$72.74 - $92.5 $553,624 - $704,017	-7,611 Reduced 25.92%	21,756 $1.86 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $3,025 - $4,979	-63 Reduced 0.21%	29,367 $2.15 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $68,135 - $116,079	1,844 Added 6.68%	29,430 $1.53 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $4,282 - $5,154	91 Added 0.33%	27,586 $1.55 Million
Q3 2019 Oct 30, 2019	BUY	$47.45 - $58.05 $336,373 - $411,516	7,089 Added 34.74%	27,495 $1.31 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $98,150 - $135,525	-2,500 Reduced 10.91%	20,406 $1.11 Million
Q1 2019 May 14, 2019	BUY	$29.84 - $43.92 $32,734 - $48,180	1,097 Added 5.03%	22,906 $930,000
Q4 2018 Feb 06, 2019	BUY	$29.95 - $46.34 $35,071 - $54,264	1,171 Added 5.67%	21,809 $680,000
Q3 2018 Nov 15, 2018	BUY	$40.12 - $45.55 $8,625 - $9,793	215 Added 1.05%	20,638 $940,000
Q2 2018 Aug 15, 2018	BUY	$38.72 - $42.52 $34,383 - $37,757	888 Added 4.55%	20,423 $856,000
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $1,182 - $1,421	-30 Reduced 0.15%	19,535 $802,000
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $660,318 - $815,273	19,565	19,565 $781,000

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Catalent, Inc. Transaction History